TY - JOUR A1 - Dmochewitz, Lydia A1 - Förtsch, Christina A1 - Zwerger, Christian A1 - Vaeth, Martin A1 - Felder, Edward A1 - Huber-Lang, Markus A1 - Barth, Holger T1 - A Recombinant Fusion Toxin Based on Enzymatic Inactive C3bot1 Selectively Targets Macrophages JF - PLoS ONE N2 - Background: The C3bot1 protein (~23 kDa) from Clostridium botulinum ADP-ribosylates and thereby inactivates Rho. C3bot1 is selectively taken up into the cytosol of monocytes/macrophages but not of other cell types such as epithelial cells or fibroblasts. Most likely, the internalization occurs by a specific endocytotic pathway via acidified endosomes. Methodology/Principal Findings: Here, we tested whether enzymatic inactive C3bot1E174Q serves as a macrophage-selective transport system for delivery of enzymatic active proteins into the cytosol of such cells. Having confirmed that C3bot1E174Q does not induce macrophage activation, we used the actin ADP-ribosylating C2I (~50 kDa) from Clostridium botulinum as a reporter enzyme for C3bot1E174Q-mediated delivery into macrophages. The recombinant C3bot1E174Q-C2I fusion toxin was cloned and expressed as GST-protein in Escherichia coli. Purified C3bot1E174Q-C2I was recognized by antibodies against C2I and C3bot and showed C2I-specific enzyme activity in vitro. When applied to cultured cells C3bot1E174Q-C2I ADP-ribosylated actin in the cytosol of macrophages including J774A.1 and RAW264.7 cell lines as well as primary cultured human macrophages but not of epithelial cells. Together with confocal fluorescence microscopy experiments, the biochemical data indicate the selective uptake of a recombinant C3-fusion toxin into the cytosol of macrophages. Conclusions/Significance: In summary, we demonstrated that C3bot1E174Q can be used as a delivery system for fast, selective and specific transport of enzymes into the cytosol of living macrophages. Therefore, C3-based fusion toxins can represent valuable molecular tools in experimental macrophage pharmacology and cell biology as well as attractive candidates to develop new therapeutic approaches against macrophage-associated diseases. KW - C3 KW - mammalian cells KW - clostridium botulinum KW - ADP-ribosylation toxins KW - botulinum C2 toxin KW - membrane translocation KW - bacterial toxins KW - actin filaments KW - cellular uptake KW - ribosyltransferase Y1 - 2013 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-131189 VL - 8 IS - 1 ER - TY - JOUR A1 - Leich, E. A1 - Weißbach, S. A1 - Klein, H.-U. A1 - Grieb, T. A1 - Pischimarov, J. A1 - Stühmer, T. A1 - Chatterjee, M. A1 - Steinbrunn, T. A1 - Langer, C. A1 - Eilers, M. A1 - Knop, S. A1 - Einsele, H. A1 - Bargou, R. A1 - Rosenwald, A. T1 - Multiple myeloma is affected by multiple and heterogeneous somatic mutations in adhesion- and receptor tyrosine kinase signaling molecules JF - Blood Cancer Journal N2 - Multiple myeloma (MM) is a largely incurable plasma cell malignancy with a poorly understood and heterogeneous clinical course. To identify potential, functionally relevant somatic mutations in MM, we performed whole-exome sequencing of five primary MM, corresponding germline DNA and six MM cell lines, and developed a bioinformatics strategy that also integrated published mutational data of 38 MM patients. Our analysis confirms that identical, recurrent mutations of single genes are infrequent in MM, but highlights that mutations cluster in important cellular pathways. Specifically, we show enrichment of mutations in adhesion molecules of MM cells, emphasizing the important role for the interaction of the MM cells with their microenvironment. We describe an increased rate of mutations in receptor tyrosine kinases (RTKs) and associated signaling effectors, for example, in EGFR, ERBB3, KRAS and MAP2K2, pointing to a role of aberrant RTK signaling in the development or progression of MM. The diversity of mutations affecting different nodes of a particular signaling network appears to be an intrinsic feature of individual MM samples, and the elucidation of intra- as well as interindividual redundancy in mutations that affect survival pathways will help to better tailor targeted therapeutic strategies to the specific needs of the MM patient. KW - multiple myeloma KW - somatic mutations KW - whole-exome sequencing KW - adhesion KW - receptor tyrosine kinases Y1 - 2013 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-128663 VL - 3 IS - e102 ER - TY - JOUR A1 - Schlereth, Katharina A1 - Heyl, Charlotte A1 - Krampitz, Anna-Maria A1 - Mernberger, Marco A1 - Finkernagel, Florian A1 - Scharfe, Maren A1 - Jarek, Michael A1 - Leich, Ellen A1 - Rosenwald, Andreas A1 - Stiewe, Thorsten T1 - Characterization of the p53 Cistrome - DNA Binding Cooperativity Dissects p53's Tumor Suppressor Functions JF - PLOS Genetics N2 - p53 protects us from cancer by transcriptionally regulating tumor suppressive programs designed to either prevent the development or clonal expansion of malignant cells. How p53 selects target genes in the genome in a context-and tissue-specific manner remains largely obscure. There is growing evidence that the ability of p53 to bind DNA in a cooperative manner prominently influences target gene selection with activation of the apoptosis program being completely dependent on DNA binding cooperativity. Here, we used ChIP-seq to comprehensively profile the cistrome of p53 mutants with reduced or increased cooperativity. The analysis highlighted a particular relevance of cooperativity for extending the p53 cistrome to non-canonical binding sequences characterized by deletions, spacer insertions and base mismatches. Furthermore, it revealed a striking functional separation of the cistrome on the basis of cooperativity; with low cooperativity genes being significantly enriched for cell cycle and high cooperativity genes for apoptotic functions. Importantly, expression of high but not low cooperativity genes was correlated with superior survival in breast cancer patients. Interestingly, in contrast to most p53-activated genes, p53-repressed genes did not commonly contain p53 binding elements. Nevertheless, both the degree of gene activation and repression were cooperativity-dependent, suggesting that p53-mediated gene repression is largely indirect and mediated by cooperativity-dependently transactivated gene products such as CDKN1A, E2F7 and non-coding RNAs. Since both activation of apoptosis genes with non-canonical response elements and repression of pro-survival genes are crucial for p53's apoptotic activity, the cistrome analysis comprehensively explains why p53-induced apoptosis, but not cell cycle arrest, strongly depends on the intermolecular cooperation of p53 molecules as a possible safeguard mechanism protecting from accidental cell killing. KW - cell-cycle arrest KW - gene expression KW - breast cancer KW - human genome KW - transcriptional repression KW - consensus DNA KW - in-vivo KW - apoptosis KW - network KW - damage Y1 - 2013 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-127579 SN - 1553-7404 VL - 9 IS - 8 ER - TY - JOUR A1 - Mueller, Kerstin A1 - Quandt, Jasmin A1 - Marienfeld, Ralf B. A1 - Weihrich, Petra A1 - Fiedler, Katja A1 - Claussnitzer, Melina A1 - Laumen, Helmut A1 - Vaeth, Martin A1 - Berberich-Siebelt, Frederike A1 - Serfling, Edgar A1 - Wirth, Thomas A1 - Brunner, Cornelia T1 - Octamer-dependent transcription in T cells is mediated by NFAT and \(NF-\kappa B\) JF - Nucleic Acids Research N2 - The transcriptional co-activator BOB.1/OBF.1 was originally identified in B cells and is constitutively expressed throughout B cell development. BOB.1/OBF.1 associates with the transcription factors Oct1 and Oct2, thereby enhancing octamer-dependent transcription. In contrast, in T cells, BOB.1/OBF.1 expression is inducible by treatment of cells with PMA/Ionomycin or by antigen receptor engagement, indicating a marked difference in the regulation of BOB.1/OBF.1 expression in B versus T cells. The molecular mechanisms underlying the differential expression of BOB.1/OBF.1 in T and B cells remain largely unknown. Therefore, the present study focuses on mechanisms controlling the transcriptional regulation of BOB.1/OBF.1 and Oct2 in T cells. We show that both calcineurin- and \(NF-\kappa B\)-inhibitors efficiently attenuate the expression of BOB.1/OBF.1 and Oct2 in T cells. In silico analyses of the BOB.1/OBF.1 promoter revealed the presence of previously unappreciated combined NFAT/\(NF-\kappa B\) sites. An array of genetic and biochemical analyses illustrates the involvement of the \(Ca^{2+}\)/calmodulin-dependent phosphatase calcineurin as well as NFAT and \(NF-\kappa B\) transcription factors in the transcriptional regulation of octamer-dependent transcription in T cells. Conclusively, impaired expression of BOB.1/OBF.1 and Oct2 and therefore a hampered octamer-dependent transcription may participate in T cell-mediated immunodeficiency caused by the deletion of NFAT or \(NF-\kappa B\) transcription factors. KW - germinal center formation KW - OBF-1 OCA-B KW - coactivator OBF-1 KW - gene expression KW - functional characterization KW - immunoglobulin promoters KW - OCT-1-deficient mice KW - embryonic lethality KW - endothelial cells KW - murine homolog Y1 - 2013 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-123280 SN - 1362-4962 VL - 41 IS - 4 ER - TY - JOUR A1 - Timofeev, Oleg A1 - Schlereth, Katharina A1 - Wanzel, Michael A1 - Braun, Attila A1 - Nieswandt, Bernhard A1 - Pagenstecher, Axel A1 - Rosenwald, Andreas A1 - Elsässer, Hans-Peter A1 - Stiewe, Thorsten T1 - p53 DNA Binding Cooperativity Is Essential for Apoptosis and Tumor Suppression In Vivo JF - Cell Reports N2 - Four molecules of the tumor suppressor p53 assemble to cooperatively bind proapoptotic target genes. The structural basis for cooperativity consists of interactions between adjacent DNA binding domains. Mutations at the interaction interface that compromise cooperativity were identified in cancer patients, suggesting a requirement of cooperativity for tumor suppression. We report on an analysis of cooperativity mutant p53(E177R) mice. Apoptotic functions of p53 triggered by DNA damage and oncogenes were abolished in these mice, whereas functions in cell-cycle control, senescence, metabolism, and antioxidant defense were retained and were sufficient to suppress development of spontaneous T cell lymphoma. Cooperativity mutant mice are nevertheless highly cancer prone and susceptible to different oncogene-induced tumors. Our data underscore the relevance of DNA binding cooperativity for p53-dependent apoptosis and tumor suppression and highlight cooperativity mutations as a class of p53 mutations that result in a selective loss of apoptotic functions due to an altered quaternary structure of the p53 tetramer. KW - mutant p53 KW - senescence KW - mice KW - tumorigenesis KW - restoration KW - damage responses KW - antioxidant function KW - p53-inducible regulator KW - p53-dependent apoptosis KW - cell-cycle arrest Y1 - 2013 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-122168 VL - 3 ER - TY - JOUR A1 - Beilhack, Andreas A1 - Chopra, Martin A1 - Kraus, Sabrina A1 - Schwinn, Stefanie A1 - Ritz, Miriam A1 - Mattenheimer, Katharina A1 - Mottok, Anja A1 - Rosenwald, Andreas A1 - Einsele, Hermann T1 - Non-Invasive Bioluminescence Imaging to Monitor the Immunological Control of a Plasmablastic Lymphoma-Like B Cell Neoplasia after Hematopoietic Cell Transplantation N2 - To promote cancer research and to develop innovative therapies, refined pre-clinical mouse tumor models that mimic the actual disease in humans are of dire need. A number of neoplasms along the B cell lineage are commonly initiated by a translocation recombining c-myc with the immunoglobulin heavy-chain gene locus. The translocation is modeled in the C.129S1-Ighatm1(Myc)Janz/J mouse which has been previously engineered to express c-myc under the control of the endogenous IgH promoter. This transgenic mouse exhibits B cell hyperplasia and develops diverse B cell tumors. We have isolated tumor cells from the spleen of a C.129S1-Ighatm1(Myc)Janz/J mouse that spontaneously developed a plasmablastic lymphoma-like disease. These cells were cultured, transduced to express eGFP and firefly luciferase, and gave rise to a highly aggressive, transplantable B cell lymphoma cell line, termed IM380. This model bears several advantages over other models as it is genetically induced and mimics the translocation that is detectable in a number of human B cell lymphomas. The growth of the tumor cells, their dissemination, and response to treatment within immunocompetent hosts can be imaged non-invasively in vivo due to their expression of firefly luciferase. IM380 cells are radioresistant in vivo and mice with established tumors can be allogeneically transplanted to analyze graft-versus-tumor effects of transplanted T cells. Allogeneic hematopoietic stem cell transplantation of tumor-bearing mice results in prolonged survival. These traits make the IM380 model very valuable for the study of B cell lymphoma pathophysiology and for the development of innovative cancer therapies. KW - B cells KW - T cells KW - Bioluminescence imaging KW - Bone marrow cells KW - Bone marrow transplantation KW - Cancer treatment KW - Spleen KW - Lymphomas Y1 - 2013 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-111341 ER - TY - JOUR A1 - Lückerath, Katharina A1 - Lapa, Constantin A1 - Spahmann, Annika A1 - Jörg, Gerhard A1 - Samnick, Samuel A1 - Rosenwald, Andreas A1 - Einsele, Herrmann A1 - Knop, Stefan A1 - Buck, Andreas T1 - Targeting Paraprotein Biosynthesis for Non-Invasive Characterization of Myeloma Biology N2 - Purpose Multiple myeloma is a hematologic malignancy originating from clonal plasma cells. Despite effective therapies, outcomes are highly variable suggesting marked disease heterogeneity. The role of functional imaging for therapeutic management of myeloma, such as positron emission tomography with 2-deoxy-2-[18F]fluoro-D-glucose (18F-FDG-PET), remains to be determined. Although some studies already suggested a prognostic value of 18F-FDG-PET, more specific tracers addressing hallmarks of myeloma biology, e.g. paraprotein biosynthesis, are needed. This study evaluated the amino acid tracers L-methyl-[11C]-methionine (11C-MET) and [18F]-fluoroethyl-L-tyrosine (18F-Fet) for their potential to image myeloma and to characterize tumor heterogeneity. Experimental Design To study the utility of 11C-MET, 18F-Fet and 18F-FDG for myeloma imaging, time activity curves were compared in various human myeloma cell lines (INA-6, MM1.S, OPM-2) and correlated to cell-biological characteristics, such as marker gene expression and immunoglobulin levels. Likewise, patient-derived CD138+ plasma cells were characterized regarding uptake and biomedical features. Results Using myeloma cell lines and patient-derived CD138+ plasma cells, we found that the relative uptake of 11C-MET exceeds that of 18F-FDG 1.5- to 5-fold and that of 18F-Fet 7- to 20-fold. Importantly, 11C-MET uptake significantly differed between cell types associated with worse prognosis (e.g. t(4;14) in OPM-2 cells) and indolent ones and correlated with intracellular immunoglobulin light chain and cell surface CD138 and CXCR4 levels. Direct comparison of radiotracer uptake in primary samples further validated the superiority of 11C-MET. Conclusion These data suggest that 11C-MET might be a versatile biomarker for myeloma superior to routine functional imaging with 18F-FDG regarding diagnosis, risk stratification, prognosis and discrimination of tumor subtypes. KW - Myelomas KW - Antibodies KW - Positron emission tomography KW - Myeloma cells KW - cell staining KW - lesions KW - biosynthesis KW - bone marrow cells Y1 - 2013 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-111319 ER - TY - JOUR A1 - Linsenmann, Thomas A1 - Monoranu, Camelia M. A1 - Kessler, Almuth F. A1 - Ernestus, Ralf I. A1 - Westermaier, Thomas T1 - Bone chips, fibrin glue, and osteogeneration following lateral suboccipital craniectomy: a case report JF - BMC Research Notes N2 - Background Suboccipital craniectomy is a conventional approach for exploring cerebellopontine angle lesions. A variety of techniques have been successfully employed to reconstruct a craniectomy. This is the first report about the histological findings after performing a cranioplasty by using a mixture of autologous bone chips and human allogenic fibrin glue. Case presentation A 53-year-old German woman underwent left lateral suboccipital retrosigmoidal craniectomy for treatment of trigeminal neuralgia in 2008. Cranioplasty was perfomed by using a mixture of autologous bone chips and human allogenic fibrin glue. Due to recurrent neuralgia, a second left lateral suboccipital craniectomy was performed in 2012. The intraoperative findings revealed a complete ossification of the former craniotomy including widely mature trabecular bone tissue in the histological examination. Conclusion A mixture of autologous bone chips and human allogenic fibrin glue seems to provide sufficient bone-regeneration revealed by histological and neuroradiological examinations. KW - Bone chips KW - Fibrin glue KW - Osteogeneration KW - Lateral suboccipital craniectomy Y1 - 2013 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-97346 UR - http://www.biomedcentral.com/1756-0500/6/523 ER - TY - JOUR A1 - Busch, Albert A1 - Tschernitz, Sebastian A1 - Thurner, Anette A1 - Kellersmann, Richard A1 - Lorenz, Udo T1 - Fatal Paraneoplastic Embolisms in Both Circulations in a Patient with Poorly Differentiated Neuroendocrine Tumour JF - Case Reports in Vascular Medicine N2 - Arterial embolism with lower limb ischemia is a rare manifestation of paraneoplastic hypercoagulability in cancer patients. We report a unique case of fatal thromboembolism involving both circulations associated with a poorly differentiated neuroendocrine tumor of the lung with rapid progress despite high doses of unfractioned heparin and review the current literature on anticoagulative regimen in tumour patients. KW - Medizin Y1 - 2013 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-97335 ER - TY - JOUR A1 - Sbiera, Silviu A1 - Ronchi, Cristina L. A1 - Leich, Ellen A1 - Henzel, Katharina A1 - Rosenwald, Andreas A1 - Allolio, Bruno A1 - Fassnacht, Martin T1 - Single Nucleotide Polymorphism Array Profiling of Adrenocortical Tumors - Evidence for an Adenoma Carcinoma Sequence? JF - PLoS ONE N2 - Adrenocortical tumors consist of benign adenomas and highly malignant carcinomas with a still incompletely understood pathogenesis. A total of 46 adrenocortical tumors (24 adenomas and 22 carcinomas) were investigated aiming to identify novel genes involved in adrenocortical tumorigenesis. High-resolution single nucleotide polymorphism arrays (Affymetrix) were used to detect copy number alterations (CNAs) and copy neutral losses of heterozygosity (cnLOH). Genomic clustering showed good separation between adenomas and carcinomas, with best partition including only chromosome 5, which was highly amplified in 17/22 malignant tumors. The malignant tumors had more relevant genomic aberrations than benign tumors, such as a higher median number of recurrent CNA (2631 vs 94), CNAs >100 Kb (62.5 vs 7) and CN losses (72.5 vs 5.5), and a higher percentage of samples with cnLOH (91% vs 29%). Within the carcinoma cohort, a precise genetic pattern (i.e. large gains at chr 5, 7, 12, and 19, and losses at chr 1, 2, 13, 17, and 22) was associated with a better prognosis (overall survival: 72.2 vs 35.4 months, P=0.063). Interestingly, >70% of gains frequent in beningn were also present in malignant tumors. Notch signaling was the most frequently involved pathway in both tumor entities. Finally, a CN gain at imprinted “IGF2” locus chr 11p15.5 appeared to be an early alteration in a multi-step tumor progression, followed by the loss of one or two alleles, associated with increased IGF2 expression, only in carcinomas. Our study serves as database for the identification of genes and pathways, such as Notch signaling, which could be involved in the pathogenesis of adrenocortical tumors. Using these data, we postulate an adenoma-carcinoma sequence for these tumors. KW - adenomas KW - cancer diagnosis KW - cancer detection KW - carcinogenesis KW - carcinomas KW - chromosomes KW - genetic loci KW - malignant tumors KW - notch signaling Y1 - 2013 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-97218 ER - TY - THES A1 - Busch, Rhoda T1 - Redundancy and indispensability of NFATc1-isoforms in the adaptive and innate immune system T1 - Redundanz und Unentbehrlichkeit der NFATc1-Isoformen im adaptiven und natürlichen Immunsystem N2 - Peritonitis is a common disease in man, frequently caused by fungi, such as Candida albicans; however, in seldom cases opportunistic infections with Saccharomyces cerevisiae are described. Resident peritoneal macrophages (prMΦ) are the major group of phagocytic cells in the peritoneum. They express a broad range of surface pattern recognition receptors (PRR) to recognize invaders. Yeast infections are primarily detected by the Dectin-1 receptor, which triggers activation of NFAT and NF-κB pathways. The transcription of the Nfatc1 gene is directed by the two alternative promoters, inducible P1 and relatively constitutive P2 promoter. While the role of P1-directed NFATc1α-isoforms to promote survival and proliferation of activated lymphocytes is well-established, the relevance of constitutively generated NFATc1β-isoforms, mainly expressed in resting lymphocytes, myeloid and non-lymphoid cells, remains unclear. Moreover, former work at our department indicated different roles for NFATc1α- and NFATc1β-proteins in lymphocytes. Our data revealed the functional role of NFATc1 in peritoneal resident macrophages. We demonstrated that the expression of NFATc1β is required for a proper immune response of prMΦ during fungal infection-induced acute peritonitis. We identified Ccl2, a major chemokine produced in response to fungal infections by prMΦ, as a novel NFATc1 target gene which is cooperatively regulated through the NFAT- and canonical NF-κB pathways. Consequently, we showed that NFATc1β deficiency in prMΦ results in a decreased infiltration of inflammatory monocytes, leading to a delayed clearance of peritoneal fungal infection. We could further show that the expression of NFATc1β-isoforms is irrelevant for homeostasis of myeloid and adaptive immune system cells and that NFATc1α- (but not β-) isoforms are required for a normal development of peritoneal B1a cells. In contrast to the situation in myeloid cells, NFATc1β deficiency is compensated by increased expression of NFATc1α-isoforms in lymphoid cells. As a consequence, NFATc1ß is dispensable for activation of the adaptive immune system. Taken together our results illustrate the redundancy and indispensability of NFATc1-isoforms in the adaptive and innate immune system, indicating a complex regulatory system for Nfatc1 gene expression in different compartments of the immune system and likely beyond that. N2 - Peritonitis ist eine alltägliche Erkrankung des Menschen, die häufig durch Pilze wie Candida albicans verursacht wird. In seltenen Fällen sind opportunistische Infektionen mit Saccharomyces cerevisiae beschrieben. Residente peritoneale Makrophagen (prMΦ) stellen die größte Gruppe phagozytischer Zellen im Peritoneum dar. Sie exprimieren eine Vielzahl an Oberflächenrezeptoren (PRR), mit denen sie Eindringlinge erkennen. Hefeinfektionen werden dabei vorrangig durch den Dectin-1 Rezeptor erkannt, der die Signalkaskaden von NFAT und NF-κB aktiviert. Die Transkription des Nfatc1 Gens wird von zwei Promotoren gelenkt, dem induzierbaren P1-Promotor und dem relativ konstitutiven P2-Promotor. Während die Funktionen der vom P1-Promotor erzeugten NFATc1α-Isoformen beim Überleben und der Proliferation von aktivierten Lymphozyten wohl bekannt sind, blieb die Rolle der NFATc1β-Isoformen, die vor allem in ruhenden lymphoiden, myeloiden und nicht-lymphoiden Zellen exprimiert sind, bisher ungeklärt. Unser Labor konnte zudem zeigen, dass NFATc1α- und NFATc1β- Proteine unterschiedliche Funktionen in Lymphozyten haben. Unsere Daten lassen die Funktion von NFATc1 in peritonealen Makrophagen erkennen. Wir konnten zeigen, dass während einer pilzinduzierten Peritonitis die Expression von NFATc1β für eine vollständige Immunantwort der prMΦ erforderlich ist. Wir haben Ccl2, das am stärksten von prMΦ als Antwort auf Pilzinfektionen produzierte Chemokin, als neues NFATc1 Zielgen identifiziert, welches kooperativ von den NFATc1- und NF-κB-Signalwegen reguliert wird. Folglich konnten wir zeigen, dass das Fehlen von NFATc1β in prMΦ zu einer Abnahme der eindringenden entzündlichen Monozyten führt, was eine verspätete Abwehr von peritonealen Pilzinfektionen zur Folge hat. Des Weiteren konnten wir zeigen, dass die Expression von NFATc1β-Isoformen irrelevant für die Homöostase von myeloiden und adaptiven Immunzellen ist, und dass NFATc1α- (aber nicht β-) Isoformen für die normale Entwicklung von B1a-Zellen erforderlich sind. In lymphoiden Zellen wird das Fehlen von NFATc1β, im Gegensatz zur Situation in myeloiden Zellen, durch eine erhöhte Expression von NFATc1α kompensiert. Demzufolge ist NFATc1β entbehrlich für die Aktivierung des adaptiven Immunsystems. Zusammengenommen zeigen unsere Ergebnisse die Redundanz und die Unentbehrlichkeit der NFATc1-Isoformen im adaptiven und natürlichen Immunsystem, welche auf ein komplexes regulatorisches System der Genexpression von NFATc1 in den verschiedenen Kompartimenten des Immunsystems und wahrscheinlich darüber hinaus hinweist. KW - Immunsystem KW - NFATc1 KW - fungal infection KW - Ccl2 KW - Bauchfellentzündung KW - Mykose KW - Transkriptionsfaktor Y1 - 2013 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-91096 ER - TY - THES A1 - Rudolf, Ronald T1 - Transcriptional Regulation of and by NFATc1 in Lymphocytes T1 - Transkriptionelle Regulation von und durch NFATc1 in Lymphozyten N2 - The transcription factor NFATc1 has been shown to regulate the activation and differentiation of T-cells and B-cells, of DCs and megakaryocytes. Dysregulation of NFAT signaling was shown to be associated with the generation of autoimmune diseases, malignant transformation and the development of cancer [71]. The primary goal of this work was to gain insights on Nfatc1 induction and regulation in lymphocytes and to find new direct NFATc1 target genes. Three new BAC -transgenic reporter mouse strains (tgNfatc1/Egfp, tgNfatc1/DE1 and tgNfatc1/DE2) were applied to analyze Nfatc1 induction and regulation in primary murine B- and T-cells. As a result, we were able to show the persistent requirement of immunoreceptor-signaling for constant Nfatc1 induction, particularly, for NFATc1/αA expression. Furthermore, we showed that NF-κB inducing agents, such as LPS, CpG or CD40 receptor engagement, in combination with primary receptor-signals, positively contributed to Nfact1 induction in B-cells [137]. We sought to establish a new system which could help to identify direct NFATc1 target genes by means of ChIP and NGS in genom-wide approaches. We were able to successfully generate a new BAC-transgene encoding a biotinylatable short isoform of NFATc1, which is currently injected into mice oocyte at the TFM in Mainz. In addition, in vivo biotinylatable NFATc1–isoforms were cloned and stably expressed in the murine B-cell lymphoma line WEHI-231. The successful use of these cells stably overexpressing either the short NFATc1/αA or the long NFATc1/βC isoform along with the bacterial BirA biotin ligase was confirmed by intracellular stainings, FACS analysis, confocal microscopy and protein IP. By NGS, we detected 2185 genes which are specifically controlled by NFATc1/αA, and 1306 genes which are exclusively controlled by NFATc1/βC. This shows that the Nfatc1 locus encodes “two genes” which exhibit alternate, in part opposite functions. Studies on the induction of apoptosis and cell-death revealed opposed roles for the highly inducible short isoform NFATc1/αA and the constantly expressed long isoform NFATc1/βC. These findings were confirmed by whole transcriptome-sequencing performed with cells overexpressing NFATc1/αA and NFATc1/βC. Several thousand genes were found to be significantly altered in their expression profile, preferentially genes involved in apoptosis and PCD for NFATc1/βC or genes involved in transcriptional regulation and cell-cycle processes for NFATc1/αA. In addition we were able to perform ChIP-seq for NFATc1/αA and NFATc1/βC in an ab-independent approach. We found potential new target-sites, but further studies will have to address this ambitious goal in the future. In individual ChIP assays, we showed direct binding of NFATc1/αA and NFATc1/βC to the Prdm1 and Aicda promoter regions which are individually controlled by the NFATc1 isoforms. N2 - Der Transkriptionsfaktor NFATc1 wurde als Regulator der Aktivierung und Differenzierung für T-Zellen, B-Zellen, Dendritische-Zellen und Megakaryozyten beschrieben. Autoimmunerkrankungen und die Entstehung von Krebs wurden mit Fehlregulationen der NFAT-Signalwege in Verbindung gebracht [71]. Ziel dieser Arbeit war der Gewinn neuer Erkenntnisse über die Induktion und Regulation von NFATc1 in Lymphozyten. Darüber hinaus sollten Gene, welche direkt durch NFATc1 gebunden und reguliert werden, identifiziert werden. Um die Induktion und Regulation von NFATc1 in primären T- und B-Zellen untersuchen zu können, wurden drei BAC transgene Reporter Maus Linien (tgNfatc1/Egfp, tgNfatc1/DE1 and tgNfatc1/DE2) verwendet. Dadurch war es uns möglich zu zeigen, dass es einer ununterbrochenen Antigen-Rezeptor Stimulation bedarf, um NFATc1, im Besonderen die Transkription der kurzen Isoform NFATc1/αA, dauerhaft zu induzieren. Zusätzlich konnten wir zeigen, dass Induktoren wie LPS, CpG oder auch die Stimulation des CD40-Rezeptors, die die Expression des Transkriptionsfaktors NF-B zur Folge haben, einen positiven Einfluss auf die Nfatc1-Induktion haben [137]. Unser Interesse lag darin, ein System zu etablieren, dass es uns ermöglichen sollte, neue NFATc1-Zielgene durch ChIP assays und Genom-weite Sequenzierungen zu ermitteln. Es ist uns gelungen, ein neues BAC-Transgen, welches für eine in vivo biotinylierbare Variante des NFATc1/αA Proteins kodiert, zu erzeugen. Dieses Konstrukt wird zum gegenwärtigen Zeitpunkt - in Zusammenarbeit mit der Universität Mainz (TFM) - in die Vorkerne von Maus-Eizellen injiziert. Ferner wurden biotinylierbare NFATc1-Isoformen kloniert und mit Hilfe retroviraler Plasmide stabil in WEHI-231 B-Lymphom-Zellen integriert. Durch intrazellulare Färbungen, FACS-Analysen, Konfokalmikroskopie und Immunpräzipitationen konnten wir eine erfolgreiche in vivo Biotinylierung in NFATc1/αA- und NFATc1/βC-exprimierenden WEHI-231 Zellen nachweisen. Mittels Next-Generation-Sequencing, in Kollaboration mit TRON, Univ. Mainz, konnten wir 2185 Gene, die spezifisch durch NFATc1/αA kontrolliert wurden, und 1306 Gene, die ausschließlich durch die Überexpression von NFATc1/βC reguliert wurden, identifizieren. Diese Ergebnisse zeigen, dass im Nfatc1 Locus „zwei Gene“ mit alternativer, zum Teil gegensätzlicher Funktion, kodiert sind. Untersuchungen zu Apoptose und Zelltod haben entgegengesetzte Eigenschaften der stark induzierbaren, kurzen Isoform NFATc1/αA und der stetig exprimierten langen Isoform NFATc1/βC aufgezeigt. Daten von Sequenzierungen des gesamten Transkriptoms, die mit NFATc1/αA und -βC überexprimierenden WEHI-231 Zellen durchgeführt wurden (TRON, Mainz), bestätigten diese Befunde. Es zeigte sich, dass es wesentliche Veränderungen der Expressionsprofile Tausender von Genen gab. In WEHI-231-Zellen, die NFATc1/βC überexprimierten, waren viele dieser Gene an Apoptose und Zelltod beteiligt. Demgegenüber waren in NFATc1/αA-Zellen vor allem Gene betroffen, die an transkriptionaler Regulation und dem Zellzyklus beteiligt waren. Überdies war es uns möglich, ChIPseq Assays für NFATc1/αA und NFATc1/βC in einem Antikörper-unabhängigen Ansatz durchzuführen. Dadurch konnten wir neue NFATc1-Bindungstellen identifizieren. Es bedarf jedoch noch weiterer Untersuchungen, um diese Ergebnisse der Genom-weiten ChIPseq Assays zu bestätigen. Durch weitere ChIP Experimente konnten wir eine direkte Bindung von NFATc1/αA und NFATc1/βC an die regulatorischen Regionen der Prdm1- und Aicda-Gene nachweisen. Die Transkription beider Gene wurde durch die Überexpression von NFATc1/αA und -βC deutlich reguliert und spielt offenbar bei der Bildung von Plasma-B-Zellen, die für die Antikörper-Produktion verantwortlich sind, eine wesentliche Rolle. KW - Lymphozyt KW - Transkriptionsfaktor KW - Lymphozyten KW - NFATc1 KW - Lymphocytes KW - NFATc1 KW - Genregulation KW - Maus Y1 - 2013 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-83993 ER -